Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 215
News
News | 23 June 2021

Honeywell launches solutions to prevent counterfeit pharma products

The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use

News
News | 21 June 2021

Zydus and Bayer announce extension of their JV

Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline

News
News | 19 June 2021

Mangalam Drugs commissions intermediate manufacturing facility

This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent

News
News | 17 June 2021

Dr. Reddy's Laboratories asked to pay $462.5 mn to Hatchtech

The company is exploring all legal options to challenge the award.

News
News | 15 June 2021

Zydus Cadila receives tentative USFDA approval for Brivaracetam

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad

News
News | 15 June 2021

Govt. to increase Janaushadhi Kendras to 10,000

Under the PMBJP, all the districts of the country are covered and ensure easy reach of affordable medicine to the people in every nook and corner of the country

News
News | 15 June 2021

Jubilant HollisterStier to manufacture COVID-19 Vaccine COVAXIN in US

Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets

News
News | 15 June 2021

JB Chemicals PAT jumps by 101% to Rs101 Cr

The company recorded revenue of Rs 528crore as compared to Rs 444 crore, registering a growth of 19% over the corresponding quarter ended 31st March 2020

News
News | 14 June 2021

Sun Pharma’s US Specialty business to grow at 21% CAGR in 2 years

The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination

News
News | 14 June 2021

Lupin receives warning letter from U.S. FDA

The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility

News
News | 12 June 2021

Lupin donates Oxygen generation plants in Mah, MP & Gujarat

These five oxygen plants with a total capacity of 3,840 cubic meters of oxygen per day have been donated to Madhya Pradesh, Maharashtra, and Gujarat

News
News | 12 June 2021

IPCA Laboratories increases stake in Trophic Wellness to 52.35%

With the acquisition of these further shares, TWPL has now become company's subsidiary.

News
News | 12 June 2021

India aims to vaccinate 1 crore people every day

India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021

News
News | 11 June 2021

Alkem launches Perampil tablets at affordable prices

The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access

News
News | 09 June 2021

Glenmark's interim data from PMS Study on Favipiravir released

The study was conducted in patients with mild to moderate COVID-19

News
News | 08 June 2021

Lupin launches Digital Asthma Educator platform

The new platform is the latest initiative under Lupin’s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailment

News
News | 08 June 2021

Trials of three more vaccines are in advanced stage: Modi

The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age

News
News | 07 June 2021

Glenmark receives ANDA approval for theophylline extended-release tablets

Glenmark has been granted a competitive generic therapy (CGT) designation for theophylline extended-release tablets

News
News | 07 June 2021

Bayer acquires Noria and PSMA Therapeutics

Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)

News
News | 05 June 2021

Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr

The company is doubling its chemistry research capacity that should commission by Q2'FY22

Startup

Digitization